G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066
E.L. Kwak, D.R. Camidge, J. Clark, G.I. Shapiro, R.G. Maki, M.J. Ratain, B. Solomon, Y. Bang, S. Ou, R. SalgiaVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)72045-2
File:
PDF, 48 KB
english, 2009